FII Favorites: 11 smallcap stocks soar over 150% in just 1 year

News
Written by

, ETMarkets.com|

Tiny Titans

1/12

Tiny Titans

Monitoring the activities of large institutional investors can be beneficial, as they conduct extensive research. An ETMarkets study shows that foreign institutional investors (FIIs) have steadily increased their investments in 112 small-cap stocks over the last four quarters (December 2023 to September 2024). Of these, nearly 30 small-cap stocks have become multibaggers within a year, with a focus on the top 11 stocks that have surged over 150% during this period. (Data Source: ACE Equity).

iStock

Wockhardt

2/12

Wockhardt

Over the past year, the stock has surged by 409%, rising from Rs 227 to Rs 1,155.

Agencies

Neuland Laboratories

3/12

Neuland Laboratories

In the last year, the stock has experienced a 258% increase, rising from Rs 3,853 to Rs 13,803.

ETMarkets.com

Strides Pharma Science

4/12

Strides Pharma Science

The stock has grown by 212% in the past year, rising from Rs 489 to Rs 1,525.

ETMarkets.com

Techno Electric & Engineering Company

5/12

Techno Electric & Engineering Company

Over the past year, the stock has increased by 203%, rising from Rs 497 to Rs 1,505.

Getty Images

Puravankara

6/12

Puravankara

The stock has gained 193% in the last year, rising from Rs 140 to Rs 412.

ANI

BASF India

7/12

BASF India

In the past year, the stock has risen by 190%, increasing from Rs 2,508 to Rs 7,278.

ET Bureau & Agencies

Kirloskar Pneumatic Company

8/12

Kirloskar Pneumatic Company

The stock has increased by 176% over the last year, rising from Rs 559 to Rs 1,545.

Agencies

V-Mart | Buy | Target: Rs 4,250 | Potential upside: 48%

9/12

V-Mart | Buy | Target: Rs 4,250 | Potential upside: 48%

Over the past year, the stock has climbed by 175%, rising from Rs 1,623 to Rs 4,465.

Agencies

Indraprastha Medical Corporation

10/12

Indraprastha Medical Corporation

The stock has experienced a 174% increase in the last year, rising from Rs 158 to Rs 433.

ETMarkets.com

Marksans Pharma

11/12

Marksans Pharma

In the past year, the stock has surged by 167%, increasing from Rs 104 to Rs 279.

ETMarkets.com

IFCI

Over the last year, the stock has appreciated by 155%, rising from Rs 22 to Rs 57.

ETMarkets.com

Read more on

Articles You May Like

7 stocks with solid quarterly performance, yet down 25% in recent slump
AUDUSD bases near support. Stretching to new highs above swing area at 0.6505 to 0.6513.
New Zealand Q3 PPI Output +1.5% q/q (expected 0.9%) and inputs +1.9% q/q (expected 1.0%)
Germany’s Thyssenkrupp pops 8% after narrowing net loss and booking $1 billion impairment charge
Euro Soft Awaiting Breakout; Bitcoin Rockets to New Highs

Leave a Reply

Your email address will not be published. Required fields are marked *